Journal of Peking University (Health Sciences) ›› 2024, Vol. 56 ›› Issue (3): 533-540. doi: 10.19723/j.issn.1671-167X.2024.03.022

Previous Articles     Next Articles

Clinical characteristics and treatment in adults and children with histiocytic necroti-zing lymphadenitis

Xiuwen FEI1,Si LIU1,Bo WANG1,*(),Aimei DONG2   

  1. 1. Department of Emergency, Peking University First Hospital, Beijing 100034, China
    2. Department of General Practice, Peking University First Hospital, Beijing 100034, China
  • Received:2024-01-18 Online:2024-06-18 Published:2024-06-12
  • Contact: Bo WANG E-mail:bjwbdoctor@163.com

RICH HTML

  

Abstract:

Objective: To analyze the clinical data of histiocytic necrotizing lymphadenitis(HNL), comparing the similarities and differences between children and adults, to deepen the understanding of the disease by clinical physicians, and to improve diagnostic rate and reduce misdiagnosis and mistreatment. Methods: The clinical data of hospitalized patients with histiocytic necrotizing lymphadenitis diagnosed by biopsy from January 2010 to August 2023 in Peking University First Hospital were collec-ted, and the clinical features, laboratory examinations, pathological features, treatments with antibiotics and glucocorticoids, and prognosis of histiocytic necrotic lymphadenitis were analyzed. Grouped based on age, the differences of clinical characteristics, laboratory tests, treatment, and prognosis between the children group (< 16 years old) and the adult group (≥16 years old) were compared. Results: Among the 81 enrolled patients, there were 42 males and 39 females. The median age was 21(14, 29) years, the median duration of disease was 20.0(13.0, 30.0) days, and the median length of hospital stay was 13.0 (10.0, 15.0) days. The first symptoms were fever, lymphadenopathy, and both. All the patients had enlarged lymph nodes with different parts and sizes, 96.3% (78 of 81) of the patients had cervical lymphadenopathy, 50.6% (41 of 81) had bilateral cervical lymphadenopathy, 55.6% (45 of 81) had supraclavicular, axillary or inguinal lymphadenopathy, and the median lymph node diameter was 20.0(20.0, 30.0) mm. Only one patient had no fever, the other 80 patients had fever, the median peak body temperature was 39.0(38.0, 39.8) ℃. Accompanying symptoms: rash (8.6%, 7/81), fatigue (34.6%, 28/81), night sweating (8.6%, 7/81), chills (25.3%, 25/81), muscle soreness (13.6%, 11/81), and joint pain (6.2%, 5/81). There were 17 cases (21.0%, 17/81) of hepatosplenomegaly, of which 12 cases (70.6%, 12/17) were splenomegaly. 68.8%(55/80) of patients had a decrease in white blood cell (WBC) count, with 47.5%(38/80)increased in lymphocyte(LY)proportion, 53.4%(39/73) increased in high-sensitivity C-reactive protein(CRP), 79.2%(57/72) increased in erythrocyte sedimentation rate(ESR), 22.2%(18/81) increased in alanine transaminase(ALT), 27.2%(22/81) elevated in aspartate transaminase(AST), and 81.6%(62/76) elevated in lactate dehydrogenase(LDH). All the 81 patients underwent lymph node biopsy, and 77.8%(63/81) of the patients showed that most of the structures in the lymph nodes were destroyed or disappeared, and 16.0%(13/81) of the lymph nodes were still in existence, hyperplasia and normal lymph node were 1.2%(1/81) respectively, and 3.7%(3/81) had normal lymph node structures. Immunohistochemical staining was performed in 67 cases. The percentages of CD3+ and CD68(KP1)+ were respectively 97.0%(65/67), and MPO+ were 94.0%(63/67). In the study, 51 patients (63.0%, 51/81) were treated with glucocorticoid therapy after diagnosis. The median time for temperature to return to normal was 1.0(1.0, 4.0) days after glucocorticoid therapy. when the glucocorticoid treatment worked best, the body temperature could drop to normal on the same day. There were significant differences in length of stay, predisposing factors, chills, the rate of increase in high-sensitivity CRP, antibiotic and glucocorticoid treatment between the adults and children groups (P < 0.05). Conclusion: In clinical practice, if there are cases with unexplained fever, superficial lymph node enlargement, and reduced white blood cells as clinical characteristics, and general antibiotics treatment is ineffective, histiocytic necrotic lymphadenitis should be considered. Lymph node biopsy should be performed as early as possible to clarify the diagnosis, reduce misdiagnosis and mistreatment, and symptomatic treatment should be the main treatment. Glucocorticoids therapy has a definite therapeutic effect.

Key words: Histiocytic necrotic lymphadenitis, Adult, Children

CLC Number: 

  • R551.2

Table 1

Comparison of clinical condition between children and adults"

Items Children Adults Mann-Whitney U P
Length of stay/d 11.0 (9.0, 13.5) 14.0 (10.0, 17.6) 579.50 0.026
Peak temperature/℃ 39.0 (38.3, 39.0) 39.0 (38.0, 40.0) 678.00 0.242
Diameter of lymph node/mm 21.0 (18.0, 25.0) 20.0 (20.0, 30.0) 643.50 0.333
Normal time of temperature with post-glucocorticoid/d 1.0 (1.0, 3.0) 1.5 (1.0, 5.0) 154.50 0.277

Table 2

Comparison of clinical manifestation between children group and adult group"

Items Children Adults χ2/Fisher P
Precursor triggers 9.617 0.002
  No 34 (91.9) 26 (59.1)
  Yes 3 (8.1) 18 (40.9)
First symptoms 1.011 0.603
  Fever 15 (40.5) 20 (45.5)
  Swollen lymph nodes 13 (35.1) 11 (25.0)
  Double 9 (24.3) 13 (29.5)
Rash 0.445a
  No 35 (94.6) 39 (88.6)
  Yes 2 (5.4) 5 (11.4)
Fatigue 3.160 0.075
  No 28 (75.7) 25 (56.8)
  Yes 9 (24.3) 19 (43.2)
Night sweats 0.119a
  No 36 (97.3) 38 (86.4)
  Yes 1 (2.7) 6 (13.6)
Chills 4.555 0.033
  No 30 (81.1) 26 (59.1)
  Yes 7 (18.9) 18 (40.9)
Muscle soreness 0.445 0.505
  No 33 (89.2) 37 (84.1)
  Yes 4 (10.8) 7 (15.9)
Joint pain 0.369a
  No 36 (97.3) 40 (90.9)
  Yes 1 (2.7) 4 (9.1)
Hepatosplenomegaly 0.457 0.499
  No 28 (75.7) 36 (81.8)
  Yes 9 (24.3) 8 (18.2)

Table 3

Comparison of laboratory findings between children and adults"

Items Children Adults χ2/Fisher P
WBC/(×109/L) 0.045 0.832
  <3.5 25 (67.6) 30 (69.8)
  ≥3.5 12 (32.4) 13 (30.2)
CRP/(mg/L) 20.419 0.000
  <8.0 24 (75.0) 9 (22.0)
  ≥8.0 8 (25.0) 32 (78.0)
ESR/(mm/h) 0.122 0.727
  <15 7 (21.2) 7 (17.9)
  ≥15 26 (78.8) 32 (82.1)
ALT/(IU/L) 2.221 0.136
  <50 26 (70.3) 37 (84.1)
  ≥50 11 (29.7) 7 (15.9)
AST/(IU/L) 0.582 0.445
  <40 24 (64.9) 32 (72.7)
  ≥40 13 (35.1) 12 (27.3)
LDH/(IU/L) 0.288 0.592
  <240 5 (15.6) 9 (20.5)
  ≥240 27 (84.4) 35 (79.5)
ANA 0.351 0.553
  Positive 12 (34.3) 10 (27.8)
  Negative 23 (65.7) 26 (72.2)
ENA 1.000a
  Positive 3 (34.3) 3 (9.1)
  Negative 30 (85.7) 30 (90.9)
EBV antibody 0.555 0.456
  Positive 26 (83.9) 26 (76.5)
  Negative 5 (16.1) 8 (23.5)
CMV antibody 0.006 0.936
  Positive 23 (71.9) 22 (71.0)
  Negative 9 (28.1) 9 (29.0)
Human parvovirus B19 antibody 0.167a
  Positive 0 (0) 1 (50.0)
  Negative 10 (100) 1 (50.0)

Table 4

Comparison of treatment between children group and adult group"

Items Children Adults χ2 P
Antibiotics 15.548 0.000
  No 4 (10.8) 23 (52.3)
  Yes 33 (89.2) 21 (47.7)
Glucocorticoid 8.458 0.004
  No 20 (54.1) 10 (22.7)
  Yes 17 (45.9) 34 (77.3)
1 Bosch X , Guilabea A , Miquel R , et al. Enigmatic Kikucli-Fujimoto disease: A comprehensive review[J]. Am J Clin Pathol, 2004, 122 (1): 141- 152.
doi: 10.1309/YF081L4TKYWVYVPQ
2 Ohshima K , Kikuchi M , Sumiyoshi Y , et al. Proliferating cells in histiocytic necrotizing lymphadenitis[J]. Virchows Arch B Cell Pathol Incl Mol Pathol, 1991, 61 (2): 97- 100.
3 杨进孙, 王文节, 杨江华. 组织细胞坏死性淋巴结炎25例临床及病理特征分析[J]. 皖南医学院学报, 2018, 37 (1): 19- 21.
4 Lebe E . Kikuchi-Fujimoto disease[J]. Kulak Burun Bogaz Ihtis Derg, 2014, 24 (3): 164- 167.
doi: 10.5606/kbbihtisas.2014.62447
5 王艳, 巩小丽, 黄有清, 等. 组织细胞坏死性淋巴结炎误诊误治讨论[J]. 临床误诊误治, 2015, 28 (2): 31- 33.
6 Pepe F , Disma S , Teodoro C , et al. Kikuchi-Fujimoto disease: A clinicopathologic update[J]. Pathologica, 2016, 108 (3): 120- 129.
7 Xu Z , Liu Y , Li H , et al. Detection of mycobacterial and viral DNA in Kikuchi-Fujimoto disease: An analysis of 153 Chinese pediatric cases[J]. Sci China Life Sci, 2017, 60 (7): 775- 777.
doi: 10.1007/s11427-017-9087-6
8 Hall LD , Eminger LA , Hesterman KS , et al. Epstein-Barr virus: Dermatologic associations and implications: Part Ⅰ. Mucocutaneous manifestations of Epstein-Barr virus and nonmalignant disorders[J]. J Am Acad Dermatol, 2015, 72 (1): 1- 19.
doi: 10.1016/j.jaad.2014.07.034
9 Deaver D , Horna P , Cualing H , et al. Pathogenesis, diagnosis, and management of Kikuchi-Fujimoto disease[J]. Cancer Control, 2014, 21 (4): 313- 321.
doi: 10.1177/107327481402100407
10 Chong Y , Kang CS . Causative agents of Kikuchi-Fujimoto disease (histiocytic necrotizing lymphadenitis): A meta analysis[J]. Int J Pediatr Otorhinolaryngol, 2014, 78 (11): 1890- 1897.
doi: 10.1016/j.ijporl.2014.08.019
11 Feder HM Jr , Liu J , Rezuke WN . Kikuchi disease in connecticut[J]. J Pediatr, 2014, 164 (1): 196- 200.
doi: 10.1016/j.jpeds.2013.08.041
12 Fiorella ML , Gelardi M , Marzullo A , et al. Kikuchi-Fujimoto disease: An uncommon cause of neck swelling[J]. Eur Arch Otorhinolaryngol, 2017, 274 (3): 1761- 1764.
doi: 10.1007/s00405-016-4147-6
13 Dalugama C , Gawarammana IB . Fever with lym-phadenopathy: Kikuchi-Fujimoto disease, a great masquerader[J]. J Med Case Rep, 2017, 11 (1): 349.
doi: 10.1186/s13256-017-1521-y
14 Jung IY , Ann HW , Kim JJ , et al. The incidence and clinical characteristics by gender differences in patients with Kikuchi-Fujimoto disease[J]. Medicine (Baltimore), 2017, 96 (11): e6332.
doi: 10.1097/MD.0000000000006332
15 Perry AM , Choi SM . Kikuchi-Fujimoto disease: A review[J]. Arch Pathol Lab Med, 2018, 142 (11): 1341- 1346.
doi: 10.5858/arpa.2018-0219-RA
16 王宁, 王尧, 王晓, 等. 51例菊池病患者临床资料回顾性分析[J]. 内科理论与实践, 2019, 14 (4): 214- 218.
17 Yen HR , Lin PY , Chuang WY , et al. Skin manifestations of Kikuchi-Fujimoto disease: Case report and review[J]. Eur J Pediatr, 2004, 163 (4/5): 210- 213.
18 费秀文, 迟春花, 狄娜, 等. 组织增生坏死性淋巴结炎一例[J]. 中华全科医师杂志, 2020, 19 (3): 253- 255.
19 刘改萍, 田芳. 组织细胞坏死性淋巴结炎9例临床病理及彩超变化的探讨[J]. 山西医科大学学报, 2006, 37 (4): 402- 404.
20 郑杨. 组织细胞坏死性淋巴结炎的诊断、鉴别诊断及其治疗[J]. 中国医刊, 2010, 45 (12): 12- 15.
21 Dumas G , Prendki V , Haroche J , et al. Kikuchi-Fujimoto disease: Retrospective study of 91 case sand review of the literature[J]. Medicine (Baltimore), 2014, 93 (24): 372- 382.
22 宋红杰, 马捷. 组织细胞坏死性淋巴结炎的研究进展[J]. 临床与实验病理学杂志, 2015, 31 (5): 569- 571.
23 Bezek S , Tucci V , Kalra S , et al. State of the globe: Time tore visit Kikuchi-Fujimoto disease[J]. J Glob Infect Dis, 2014, 6 (4): 139- 140.
[1] Yifan WU,Yingxiang YU,Lan XIE,Zhida ZHANG,Cuiqing CHANG. Characteristics of resting energy expenditure and evaluation of prediction formulas in young men with different body mass indexes [J]. Journal of Peking University (Health Sciences), 2024, 56(2): 247-252.
[2] Hai-hong YAO,Fan YANG,Su-mei TANG,Xia ZHANG,Jing HE,Yuan JIA. Clinical characteristics and diagnostic indicators of macrophage activation syndrome in patients with systemic lupus erythematosus and adult-onset Still's disease [J]. Journal of Peking University (Health Sciences), 2023, 55(6): 966-974.
[3] Zi-xuan XUE,Shi-ying TANG,Min QIU,Cheng LIU,Xiao-jun TIAN,Min LU,Jing-han DONG,Lu-lin MA,Shu-dong ZHANG. Clinicopathologic features and prognosis of young renal tumors with tumor thrombus [J]. Journal of Peking University (Health Sciences), 2023, 55(5): 802-811.
[4] Xiao-jin YAN,Yun-fei LIU,Ning MA,Jia-jia DANG,Jing-shu ZHANG,Pan-liang ZHONG,Pei-jin HU,Yi SONG,Jun MA. Assessment of prevalence of malnutrition among Chinese primary and secondary school students and analysis of policy effect during the period of the Program for the Development of Chinese Children 2011-2020 [J]. Journal of Peking University (Health Sciences), 2023, 55(4): 593-599.
[5] Ting WANG,Qiao-sheng LI,Hao-ran LIU,Wei-yan JIAN. Urban-rural differentials in the relationship between personality traits and changes in depressive symptoms [J]. Journal of Peking University (Health Sciences), 2023, 55(3): 385-391.
[6] Xiao-yi MI,Shan-shan HOU,Zi-yuan FU,Mo ZHOU,Xin-xuan LI,Zhao-xue MENG,Hua-fang JIANG,Hong Zhou. Reliability and validity of the Chinese version of adverse childhood experiences international questionnaire in parents of preschool children [J]. Journal of Peking University (Health Sciences), 2023, 55(3): 408-414.
[7] Meng-jie CUI,Qi MA,Man-man CHEN,Tao MA,Xin-xin WANG,Jie-yu LIU,Yi ZHANG,Li CHEN,Jia-nuo JIANG,Wen YUAN,Tong-jun GUO,Yan-hui DONG,Jun MA,Yi XING. Association between different growth patterns and metabolic syndrome in children and adolescents aged 7 to 17 years [J]. Journal of Peking University (Health Sciences), 2023, 55(3): 415-420.
[8] Jia-jia DANG,Shan CAI,Pan-liang ZHONG,Ya-qi WANG,Yun-fei LIU,Di SHI,Zi-yue CHEN,Yi-hang ZHANG,Pei-jin HU,Jing LI,Jun MA,Yi SONG. Association of outdoor artificial light at night exposure with overweight and obesity among children and adolescents aged 9 to 18 years in China [J]. Journal of Peking University (Health Sciences), 2023, 55(3): 421-428.
[9] Wei YONG,Kun QIAN,Wen-hao ZHU,Xiao-yi ZHAO,Chang LIU,Jie PAN. X-ray evaluation of pulp calcification in adult permanent teeth after pulpotomy [J]. Journal of Peking University (Health Sciences), 2023, 55(1): 88-93.
[10] Ya-xi CUI,Jun-bao DU,Qing-you ZHANG,Ying LIAO,Ping LIU,Yu-li WANG,Jian-guang QI,Hui YAN,Wen-rui XU,Xue-qin LIU,Yan SUN,Chu-fan SUN,Chun-yu ZHANG,Yong-hong CHEN,Hong-fang JIN. A 10-year retrospective analysis of spectrums and treatment options of orthostatic intolerance and sitting intolerance in children [J]. Journal of Peking University (Health Sciences), 2022, 54(5): 954-960.
[11] Tao MA,Yan-hui LI,Man-man CHEN,Ying MA,Di GAO,Li CHEN,Qi MA,Yi ZHANG,Jie-yu LIU,Xin-xin WANG,Yan-hui DONG,Jun MA. Associations between early onset of puberty and obesity types in children: Based on both the cross-sectional study and cohort study [J]. Journal of Peking University (Health Sciences), 2022, 54(5): 961-970.
[12] Hai-long HE,Qing LI,Tao XU,Xiao-wei ZHANG. Treatment of adult-acquired buried penis with suprapubic liposuction combined with modified Devine operation [J]. Journal of Peking University (Health Sciences), 2022, 54(4): 741-745.
[13] YAN Hui,PANG Lu,LI Xue-ying,YANG Wen-shuang,JIANG Shi-ju,LIU Ping,YAN Cun-ling. Incidence and cause of abnormal cholesterol in children aged 2-18 years in a single center [J]. Journal of Peking University (Health Sciences), 2022, 54(2): 217-221.
[14] CHEN Man-man,YANG Zhao-geng,SU Bin-bin,LI Yan-hui,GAO Di,MA Ying,MA Tao,DONG Yan-hui,MA Jun. Analysis on the law of height growth spurt in adolescence of children and adolescents in Zhongshan City [J]. Journal of Peking University (Health Sciences), 2021, 53(3): 506-510.
[15] LIU Xiao-qiang,YANG Yang,ZHOU Jian-feng,LIU Ming-yue,TAN Jian-guo. Three-dimensional movement of posterior teeth after losing the interproximal and occlusal contacts in adults [J]. Journal of Peking University (Health Sciences), 2021, 53(3): 594-597.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] Author. English Title Test[J]. Journal of Peking University(Health Sciences), 2010, 42(1): 1 -10 .
[2] . [J]. Journal of Peking University(Health Sciences), 2009, 41(4): 456 -458 .
[3] . [J]. Journal of Peking University(Health Sciences), 2009, 41(2): 125 -128 .
[4] . [J]. Journal of Peking University(Health Sciences), 2009, 41(2): 135 -140 .
[5] . [J]. Journal of Peking University(Health Sciences), 2009, 41(2): 158 -161 .
[6] . [J]. Journal of Peking University(Health Sciences), 2009, 41(2): 188 -191 .
[7] . [J]. Journal of Peking University(Health Sciences), 2009, 41(2): 217 -220 .
[8] . [J]. Journal of Peking University(Health Sciences), 2009, 41(1): 52 -55 .
[9] . [J]. Journal of Peking University(Health Sciences), 2009, 41(1): 109 -111 .
[10] . [J]. Journal of Peking University(Health Sciences), 2009, 41(3): 297 -301 .